These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 18425537

  • 21. Secondary failure of plasma therapy in factor H deficiency.
    Nathanson S, Ulinski T, Frémeaux-Bacchi V, Deschênes G.
    Pediatr Nephrol; 2006 Nov; 21(11):1769-71. PubMed ID: 16909242
    [Abstract] [Full Text] [Related]

  • 22. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.
    Martinez-Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, Skerka C, Zipfel PF, Goodship T, Noris M, Remuzzi G, de Cordoba SR, European Working Party on the Genetics of HUS.
    J Am Soc Nephrol; 2008 Mar; 19(3):639-46. PubMed ID: 18235085
    [Abstract] [Full Text] [Related]

  • 23. Alternative complement pathway assessment in patients with atypical HUS.
    Roumenina LT, Loirat C, Dragon-Durey MA, Halbwachs-Mecarelli L, Sautes-Fridman C, Fremeaux-Bacchi V.
    J Immunol Methods; 2011 Feb 28; 365(1-2):8-26. PubMed ID: 21215749
    [Abstract] [Full Text] [Related]

  • 24. Atypical hemolytic uremic syndrome.
    Kavanagh D, Goodship TH.
    Curr Opin Hematol; 2010 Sep 28; 17(5):432-8. PubMed ID: 20613506
    [Abstract] [Full Text] [Related]

  • 25. Complement regulatory genes and hemolytic uremic syndromes.
    Kavanagh D, Richards A, Atkinson J.
    Annu Rev Med; 2008 Sep 28; 59():293-309. PubMed ID: 17705684
    [Abstract] [Full Text] [Related]

  • 26. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P, Dickenmann M, Schifferli JA.
    Nephron Clin Pract; 2010 Sep 28; 114(4):c219-35. PubMed ID: 20090363
    [Abstract] [Full Text] [Related]

  • 27. Favorable long-term outcomes of isolated liver transplantation in a child with atypical hemolytic uremic syndrome caused by a novel complement factor H mutation
.
    Cho H, Lee Y.
    Clin Nephrol; 2017 Jul 28; 88(1):52-56. PubMed ID: 28502324
    [Abstract] [Full Text] [Related]

  • 28. Challenges in the management of infantile factor H associated hemolytic uremic syndrome.
    Filler G, Radhakrishnan S, Strain L, Hill A, Knoll G, Goodship TH.
    Pediatr Nephrol; 2004 Aug 28; 19(8):908-11. PubMed ID: 15206027
    [Abstract] [Full Text] [Related]

  • 29. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE, Abarrategui-Garrido C, Frémeaux-Bacchi V, Goicoechea de Jorge E, Goodship TH, López Trascasa M, Noris M, Ponce Castro IM, Remuzzi G, Rodríguez de Córdoba S, Sánchez-Corral P, Skerka C, Zipfel PF, Perkins SJ.
    Hum Mutat; 2007 Mar 28; 28(3):222-34. PubMed ID: 17089378
    [Abstract] [Full Text] [Related]

  • 30. Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS).
    Roumenina LT, Roquigny R, Blanc C, Poulain N, Ngo S, Dragon-Durey MA, Frémeaux-Bacchi V.
    Methods Mol Biol; 2014 Mar 28; 1100():237-47. PubMed ID: 24218264
    [Abstract] [Full Text] [Related]

  • 31. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V, Bonucchi D, De Amicis S, Americo C, Ghiandai G, Cappelli G.
    Transplant Proc; 2010 May 28; 42(4):1352-4. PubMed ID: 20534299
    [Abstract] [Full Text] [Related]

  • 32. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
    Davin JC, Gracchi V, Bouts A, Groothoff J, Strain L, Goodship T.
    Am J Kidney Dis; 2010 Apr 28; 55(4):708-11. PubMed ID: 19854549
    [Abstract] [Full Text] [Related]

  • 33. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK, Kıhtır HS, Goknar N, Ersoy M, Akcay N, Sevketoglu E.
    Pediatr Nephrol; 2018 Jun 28; 33(6):1093-1096. PubMed ID: 29558000
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Novel use of intravenous immunoglobulin G in complement factor H missense mutation: a case report.
    Neidich AB, Neidich EM, Lee A, Nicoletta J, Rohrer RJ, Milner LS, Cooper JT.
    Prog Transplant; 2013 Sep 28; 23(3):213-6. PubMed ID: 23996939
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Update on evaluating complement in hemolytic uremic syndrome.
    Kavanagh D, Goodship TH.
    Curr Opin Nephrol Hypertens; 2007 Nov 28; 16(6):565-71. PubMed ID: 18089972
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Atypical hemolytic uremic syndrome: telling the difference between H and Y.
    Goicoechea de Jorge E, Pickering MC.
    Kidney Int; 2010 Oct 28; 78(8):721-3. PubMed ID: 20877372
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.